
Farina Arreguin/LinkedIn
May 26, 2025, 15:55
Farina Arreguin: Chemo-Immunotherapy Has Improved the Care of Patients With Relapsed/Refractory Neuroblastoma
Farina Arreguin, Professor of Pediatric Oncology Subspecialty at ISSSTE National Medical Center, shared a post on X:
“Chemo-Immunotherapy has improved the care of patients with relapsed/refractory neuroblastoma ..”
More posts featuring Farina Arreguin.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 26, 2025, 15:37
May 26, 2025, 13:46
May 26, 2025, 13:08
May 26, 2025, 12:58